|
1
|
Katiyar SK, Meeran SM, Katiyar N and
Akhtar S: p53 cooperates berberine-induced growth inhibition and
apoptosis of non-small cell human lung cancer cells in vitro and
tumor xenograft growth in vivo. Mol Carcinog. 48:24–37. 2009.
View Article : Google Scholar
|
|
2
|
Iizuka N, Miyamoto K, Okita K, Tangoku A,
Hayashi H, Yosino S, Abe T, Morioka T, Hazama S and Oka M:
Inhibitory effect of Coptidis Rhizoma and berberine on the
proliferation of human esophageal cancer cell lines. Cancer Lett.
148:19–25. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mantena SK, Sharma SD and Katiyar SK:
Berberine inhibits growth, induces G1 arrest and apoptosis in human
epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin
cascade, disruption of mitochondrial membrane potential and
cleavage of caspase 3 and PARP. Carcinogenesis. 27:2018–2027. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patil JB, Kim J and Jayaprakasha GK:
Berberine induces apoptosis in breast cancer cells (MCF-7) through
mitochondrial-dependent pathway. Eur J Pharmacol. 645:70–78. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang X, Gu L, Li J, Shah N, He J, Yang L,
Hu Q and Zhou M: Degradation of MDM2 by the interaction between
berberine and DAXX leads to potent apoptosis in MDM2-overexpressing
cancer cells. Cancer Res. 70:9895–9904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donehower LA, Harvey M, Slagle BL,
McArthur MJ, Montgomery CA Jr, Butel JS and Bradley A: Mice
deficient for p53 are developmentally normal but susceptible to
spontaneous tumours. Nature. 356:215–221. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zou B, Chim CS, Pang R, Zeng H, Dai Y,
Zhang R, Lam CS, Tan VP, Hung IF, Lan HY, et al: XIAP-associated
factor 1 (XAF1), a novel target of p53, enhances p53-mediated
apoptosis via post-translational modification. Mol Carcinog.
51:422–432. 2012. View
Article : Google Scholar
|
|
8
|
Lin CC, Yang JS, Chen JT, Fan S, Yu FS,
Yang JL, Lu CC, Kao MC, Huang AC, Lu HF, et al: Berberine induces
apoptosis in human HSC-3 oral cancer cells via simultaneous
activation of the death receptor-mediated and mitochondrial
pathway. Anticancer Res. 27A:3371–3378. 2007.
|
|
9
|
Liston P, Fong WG, Kelly NL, Toji S,
Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW and Korneluk
RG: Identification of XAF1 as an antagonist of XIAP anti-caspase
activity. Nat Cell Biol. 3:128–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fong WG, Liston P, Rajcan-Separovic E, St
Jean M, Craig C and Korneluk RG: Expression and genetic analysis of
XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics.
70:113–122. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arora V, Cheung HH, Plenchette S, Micali
OC, Liston P and Korneluk RG: Degradation of survivin by the
X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J Biol Chem.
282:26202–26209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Byun DS, Cho K, Ryu BK, Lee MG, Kang MJ,
Kim HR and Chi SG: Hypermethylation of XIAP-associated factor 1, a
putative tumor suppressor gene from the 17p13.2 locus, in human
gastric adenocarcinomas. Cancer Res. 63:7068–7075. 2003.PubMed/NCBI
|
|
13
|
Hildesheim J, Bulavin DV, Anver MR, Alvord
WG, Hollander MC, Vardanian L and Fornace AJ Jr: Gadd45a protects
against UV irradiation-induced skin tumors, and promotes apoptosis
and stress signaling via MAPK and p53. Cancer Res. 62:7305–7315.
2002.PubMed/NCBI
|
|
14
|
Mita H, Tsutsui J, Takekawa M, Witten EA
and Saito H: Regulation of MTK1/MEKK4 kinase activity by its
N-terminal autoinhibitory domain and GADD45 binding. Mol Cell Biol.
22:4544–4555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takekawa M and Saito H: A family of
stress-inducible GADD45-like proteins mediate activation of the
stress-responsive MTK1/MEKK4 MAPKKK. Cell. 95:521–530. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bulavin DV, Saito S, Hollander MC,
Sakaguchi K, Anderson CW, Appella E and Fornace AJ Jr:
Phosphorylation of human p53 by p38 kinase coordinates N-terminal
phosphorylation and apoptosis in response to UV radiation. EMBO J.
18:6845–6854. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buschmann T, Potapova O, Bar-Shira A,
Ivanov VN, Fuchs SY, Henderson S, Fried VA, Minamoto T,
Alarcon-Vargas D, Pincus MR, et al: Jun NH2-terminal kinase
phosphorylation of p53 on Thr-81 is important for p53 stabilization
and transcriptional activities in response to stress. Mol Cell
Biol. 21:2743–2754. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takemoto S, Trovato R, Cereseto A, Nicot
C, Kislyakova T, Casareto L, Waldmann T, Torelli G and Franchini G:
p53 stabilization and functional impairment in the absence of
genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex
vivo and cultured adult T-cell leukemia/lymphoma cells. Blood.
95:3939–3944. 2000.PubMed/NCBI
|
|
19
|
Park GB, Kim YS, Lee HK, Song H, Cho DH,
Lee WJ and Hur DY: Endoplasmic reticulum stress-mediated apoptosis
of EBV-transformed B cells by cross-linking of CD70 is dependent
upon generation of reactive oxygen species and activation of p38
MAPK and JNK pathway. J Immunol. 185:7274–7284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chidambara Murthy KN, Jayaprakasha GK and
Patil BS: The natural alkaloid berberine targets multiple pathways
to induce cell death in cultured human colon cancer cells. Eur J
Pharmacol. 688:14–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu B, Hu M, Liu K and Peng J: Cytotoxicity
of berberine on human cervical carcinoma HeLa cells through
mitochondria, death receptor and MAPK pathways, and in-silico
drug-target prediction. Toxicol In Vitro. 24:1482–1490. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu B, Yu H, Chow C, Li B, Zheng W, Davis
RJ and Flavell RA: GADD45gamma mediates the activation of the p38
and JNK MAP kinase pathways and cytokine production in effector TH1
cells. Immunity. 14:583–590. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Komarov PG, Komarova EA, Kondratov RV,
Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV: A chemical
inhibitor of p53 that protects mice from the side effects of cancer
therapy. Science. 285:1733–1737. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Murphy PJ, Galigniana MD, Morishima Y,
Harrell JM, Kwok RP, Ljungman M and Pratt WB: Pifithrin-alpha
inhibits p53 signaling after interaction of the tumor suppressor
protein with hsp90 and its nuclear translocation. J Biol Chem.
279:30195–30201. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsuzawa A and Ichijo H:
Stress-responsive protein kinases in redox-regulated apoptosis
signaling. Antioxid Redox Signal. 7:472–481. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lau CW, Yao XQ, Chen ZY, Ko WH and Huang
Y: Cardiovascular actions of berberine. Cardiovasc Drug Rev.
19:234–244. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jantova S, Cipak L and Letasiova S:
Berberine induces apoptosis through a mitochondrial/caspase pathway
in human promonocytic U937 cells. Toxicol In Vitro. 21:25–31. 2007.
View Article : Google Scholar
|
|
28
|
Lin CC, Kao ST, Chen GW, Ho HC and Chung
JG: Apoptosis of human leukemia HL-60 cells and murine leukemia
WEHI-3 cells induced by berberine through the activation of
caspase-3. Anticancer Res. 26A:227–242. 2006.
|
|
29
|
Levine AJ: p53, the cellular gatekeeper
for growth and division. Cell. 88:323–331. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Perdomo JA, Naomoto Y, Haisa M, Fujiwara
T, Hamada M, Yasuoka Y and Tanaka N: In vivo influence of p53
status on proliferation and chemoradiosensitivity in non-small-cell
lung cancer. J Cancer Res Clin Oncol. 124:10–18. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lai SL, Perng RP and Hwang J: p53 gene
status modulates the chemosensitivity of non-small cell lung cancer
cells. J Biomed Sci. 7:64–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Perez-Soler R, Kemp B, Wu QP, Mao L, Gomez
J, Zeleniuch-Jacquotte A, Yee H, Lee JS, Jagirdar J and Ling YH:
Response and determinants of sensitivity to paclitaxel in human
non-small cell lung cancer tumors heterotransplanted in nude mice.
Clin Cancer Res. 6:4932–4938. 2000.
|
|
34
|
Oizumi S, Isobe H, Ogura S, Ishida T,
Yamazaki K, Nishimura M, Kawakami Y and Dosaka-Akita H:
Topoisomerase inhibitor-induced apoptosis accompanied by
down-regulation of Bcl-2 in human lung cancer cells. Anticancer
Res. 22C:4029–4037. 2002.
|
|
35
|
McCurrach ME, Connor TM, Knudson CM,
Korsmeyer SJ and Lowe SW: bax-deficiency promotes drug resistance
and oncogenic transformation by attenuating p53-dependent
apoptosis. Proc Natl Acad Sci USA. 94:2345–2349. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ryan KM, Phillips AC and Vousden KH:
Regulation and function of the p53 tumor suppressor protein. Curr
Opin Cell Biol. 13:332–337. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
LaCasse EC, Baird S, Korneluk RG and
MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging
role in cancer. Oncogene. 17:3247–3259. 1998. View Article : Google Scholar
|
|
38
|
Holcik M, Gibson H and Korneluk RG: XIAP:
Apoptotic brake and promising therapeutic target. Apoptosis.
6:253–261. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferreira CG, van der Valk P, Span SW,
Jonker JM, Postmus PE, Kruyt FA and Giaccone G: Assessment of IAP
(inhibitor of apoptosis) proteins as predictors of response to
chemotherapy in advanced non-small-cell lung cancer patients. Ann
Oncol. 12:799–805. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang J, Yao WY, Zhu Q, Tu SP, Yuan F,
Wang HF, Zhang YP and Yuan YZ: XAF1 as a prognostic biomarker and
therapeutic target in pancreatic cancer. Cancer Sci. 101:559–567.
2010. View Article : Google Scholar
|
|
41
|
Lee MG, Huh JS, Chung SK, Lee JH, Byun DS,
Ryu BK, Kang MJ, Chae KS, Lee SJ, Lee CH, et al: Promoter CpG
hypermethylation and downregulation of XAF1 expression in human
urogenital malignancies: Implication for attenuated p53 response to
apoptotic stresses. Oncogene. 25:5807–5822. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tu SP, Liston P, Cui JT, Lin MC, Jiang XH,
Yang Y, Gu Q, Jiang SH, Lum CT, Kung HF, et al: Restoration of XAF1
expression induces apoptosis and inhibits tumor growth in gastric
cancer. Int J Cancer. 125:688–697. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tu SP, Sun YW, Cui JT, Zou B, Lin MC, Gu
Q, Jiang SH, Kung HF, Korneluk RG and Wong BC: Tumor suppressor
XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis
factor-related apoptosis-inducing ligand to suppress colon cancer
growth and trigger tumor regression. Cancer. 116:1252–1263. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Harris SL and Levine AJ: The p53 pathway:
Positive and negative feedback loops. Oncogene. 24:2899–2908. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu J, Zhang X, Liu A, Liu S, Zhang L, Wu
B and Hu Q: Berberine induces apoptosis in p53-null leukemia cells
by down-regulating XIAP at the post-transcriptional level. Cell
Physiol Biochem. 32:1213–1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dubrez L, Coll JL, Hurbin A, de Fraipont
F, Lantejoul S and Favrot MC: Cell cycle arrest is sufficient for
p53-mediated tumor regression. Gene Ther. 8:1705–1712. 2001.
View Article : Google Scholar
|
|
47
|
Schneider-Stock R, Diab-Assef M, Rohrbeck
A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner
A and Gali-Muhtasib H: 5-Aza-cytidine is a potent inhibitor of DNA
methyltransferase 3a and induces apoptosis in HCT-116 colon cancer
cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp
Ther. 312:525–536. 2005. View Article : Google Scholar
|
|
48
|
Lakin ND and Jackson SP: Regulation of p53
in response to DNA damage. Oncogene. 18:7644–7655. 1999. View Article : Google Scholar
|
|
49
|
Kaji A, Zhang Y, Nomura M, Bode AM, Ma WY,
She QB and Dong Z: Pifithrin-alpha promotes p53-mediated apoptosis
in JB6 cells. Mol Carcinog. 37:138–148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Proietti De Santis L, Balajee AS, Lorenti
Garcia C, Pepe G, Worboys AM and Palitti F: Inhibition of p53, p21
and Bax by pifithrin-alpha does not affect UV induced apoptotic
response in CS-B cells. DNA Repair (Amst). 2:891–900. 2003.
View Article : Google Scholar
|
|
51
|
Chou TT, Trojanowski JQ and Lee VM: p38
mitogen-activated protein kinase-independent induction of gadd45
expression in nerve growth factor-induced apoptosis in
medulloblastomas. J Biol Chem. 276:41120–41127. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mak SK and Kültz D: Gadd45 proteins induce
G2/M arrest and modulate apoptosis in kidney cells exposed to
hyperosmotic stress. J Biol Chem. 279:39075–39084. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chiu WH, Luo SJ, Chen CL, Cheng JH, Hsieh
CY, Wang CY, Huang WC, Su WC and Lin CF: Vinca alkaloids cause
aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA
damage, mitochondrial dysfunction, and apoptosis in lung
adenocarcinoma cells. Biochem Pharmacol. 83:1159–1171. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Park GB, Choi Y, Kim YS, Lee HK, Kim D and
Hur DY: ROS and ERK1/2-mediated caspase-9 activation increases XAF1
expression in dexamethasone-induced apoptosis of EBV-transformed B
cells. Int J Oncol. 43:29–38. 2013.PubMed/NCBI
|
